Affiliation:
1. VCU‐Shenandoah Family Practice Residency Front Royal Virginia USA
2. Department of Family Medicine and Population Health Virginia Commonwealth University Richmond Virginia USA
3. Larry A. Green Center Richmond Virginia USA
Abstract
AbstractBackgroundAntipsychotic prescribing in United States nursing homes (NHs) has decreased since the Center for Medicare & Medicaid Service debuted the National Partnership to Improve Dementia Care in Nursing Homes (NP); however, reductions have stalled. To help explain persistent antipsychotic use despite the NP's reduction efforts, the perspectives of diverse NP stakeholders were qualitatively assessed. This study aimed to re‐evaluate these individual perspectives in combined thematic synthesis to discover NP improvement opportunities undetectable in single stakeholder assessments.MethodsThematic synthesis. Through immersive crystallisation, original source coding results were organised into related descriptive themes. Similarities and differences were identified, and descriptive themes were regrouped into new, increasingly abstract, analytical themes. This cycle continued until variances were resolved and analytic themes sufficiently described and explained all initial descriptive themes.ResultsThree analytic themes emerged regarding NP improvement opportunities. The NP's positive impacts would be augmented by: (i) a deeper and expanded appreciation of stakeholder perspectives; (ii) more urgent and rapid adaptation to unintended adverse outcomes; and (iii) greater recognition of the contextual and environmental factors influencing decisions to prescribe or not prescribe antipsychotic medications. Stakeholder groups described: perspectives they perceived as inadequately considered by the NP; insufficient NP engagement with the stakeholders capable of creating evidenced, affordable, and available non‐pharmacologic therapies for dementia symptoms; recognition that dementia interventions effective for a specific individual at a specific time in a specific community may not generalise; and diverse ongoing undesirable outcomes from NP policies that could be mitigated by NP modifications.ConclusionsThe NP has done much to advance dementia care in NHs. Notwithstanding, these results suggest the NP would only be improved through increasingly comprehensive inclusion of stakeholder perspectives, enhanced incorporation of individual contextual factors, and a more decisive mechanism for ongoing and continual adaptation.
Reference25 articles.
1. National Partnership to Improve Dementia Care in Nursing Homes.Antipsychotic Medication Use Data Report (April 2022) 2022. Available from:https://www.cms.gov/files/document/antipsychotic-medication-use-data-report-2021q4-updated-07292022.pdf.
2. CMS Announces National Partnership to Improve Dementia Care in Nursing Homes 2012. Available from:https://www.cms.gov/Newsroom/MediaReleaseDatabase/Press‐Releases/2012‐Press‐Releases‐Items/2012‐05‐30.html.
3. FDA NEWS RELEASE.FDA Requests Boxed Warnings on Older Class of Antipsychotic Drugs 2008 2008. Available from:http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116912.htm.
4. Public Quality Reporting and Nursing Home Admission Decisions
5. Primary Care Physician Perspectives about Antipsychotics and Other Medications for Symptoms of Dementia